Modern Chinese Medicine Group Co., Ltd. (HKG:1643)

HKG:1643 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	119.68	229.71	229.67	286.27	282.26	176.09
Cash & Short-Term Investments	119.68	229.71	229.67	286.27	282.26	176.09
Cash Growth	-57.75%	0.02%	-19.77%	1.42%	60.29%	140.59%
Accounts Receivable	61.52	59.94	88.48	103.09	78.09	71.49
Other Receivables	-	1.23	1	-	-	-
Receivables	61.52	61.16	89.49	103.09	78.09	71.49
Inventory	39.23	28.95	30.55	46.47	41.51	58.69
Restricted Cash	-	-	1.95	-	-	-
Other Current Assets	7.56	11.27	0.85	0.7	0.64	0.57
Total Current Assets	228	331.09	352.51	436.51	402.49	306.85
Property, Plant & Equipment	201.48	197.09	186.87	87.71	80.61	74.1
Other Intangible Assets	11.7	-	0.1	0.2	0.29	0.39
Long-Term Deferred Tax Assets	5.64	0.88	0.84	4.11	8.71	5.17
Other Long-Term Assets	15.1	14.34	-	-	9.44	9.44
Total Assets	499.19	543.4	540.31	528.53	501.53	395.94

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	19.04	30.33	32.58	31.28	39.26	28.82
Accrued Expenses	4.76	8.38	16.32	17.52	25.36	22.07
Current Portion of Leases	1.2	0.07	0.07	0.07	0.39	0.34
Current Income Taxes Payable	-	-	-	0.01	8.34	7.28
Total Current Liabilities	24.99	38.78	48.96	48.89	73.35	58.51
Long-Term Leases	-	-	0.07	-	-	0.07
Long-Term Deferred Tax Liabilities	5.8	6.63	7.05	6.76	5.25	-
Total Liabilities	30.8	45.41	56.08	55.64	78.6	58.58

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	6.1	6.1	5.01	5.01	5.01	5.01
Additional Paid-In Capital	137.09	137.09	108.67	108.67	108.67	117
Retained Earnings	291.64	317.54	331.1	321.43	272.63	184.81
Comprehensive Income & Other	33.56	37.25	39.44	37.78	36.62	30.55
Shareholders' Equity	468.4	497.99	484.23	472.89	422.93	337.36
Total Liabilities & Equity	499.19	543.4	540.31	528.53	501.53	395.94

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	1.2	0.07	0.14	0.07	0.39	0.41
Net Cash (Debt)	118.48	229.64	229.53	286.19	281.86	175.68
Net Cash Growth	-58.15%	0.05%	-19.80%	1.54%	60.44%	159.68%
Net Cash Per Share	0.16	0.35	0.38	0.48	0.47	0.30
Filing Date Shares Outstanding	720	720	600	600	600	600
Total Common Shares Outstanding	720	720	600	600	600	600
Working Capital	203	292.31	303.55	387.63	329.14	248.33
Book Value Per Share	0.65	0.69	0.81	0.79	0.70	0.56
Tangible Book Value	456.7	497.99	484.13	472.69	422.64	336.97
Tangible Book Value Per Share	0.63	0.69	0.81	0.79	0.70	0.56
Buildings	-	213.54	196.3	94.34	89.75	78.54
Machinery	-	24.36	28.55	27.53	18.67	18.16
Construction In Progress	-	3.72	-	-	-	-

Data Source: S&P Global Market Intelligence Last updated: Sep 28, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Oct 3, 2026

Data Sources Report a data error